Owner Hydra Biosciences, Inc. a Delaware corporation

Service Davies Collison Cave

Class 5 Pharmaceuticals, biologicals and genetic therapies for regenerating human tissues and organs, for blocking or promoting vessel development, and for treatment of human disease where the treatment involves generation of, interference with or effects upon one or more signaling molecules; pharmaceuticals for contraception; tests and assays for identifying molecules that can induce desirable cardiovascular, reproductive, genitourinary, gastrointestinal, infectious, hematologic, oncologic, metabolic, neurologic, pulmonary, immunologic, renal, rheumatologic, dermatologic or vision results; and tests and assays for identifying a risk of cardiovascular, reproductive, genitourinary, gastrointestinal, infectious, hemtologic, oncologic, metabolic, neurologic, pulmonary, immunologic, renal, rheumatologic, dermatologic or vision diseases

Class 10 Medical devices, including, protein sheaths, protein enhanced sheaths, pharmaceutical enhanced sheaths, stents and other delivery mechanisms with protein, protein enhanced or pharmaceutical enhanced sheaths, linings or coatings for use in regenerating and remodeling diseased blood vessels or blocking unwanted regeneration